The 10 hottest medtech startups of 2017



Technology: Infusion system

CEO: Stuart Randle


Ivenix is aiming to redesign infusion therapy from the ground up. The company has developed a fully integrated technology to support interoperability and improve safety and performance. Technology within the infusion pump category has been slow to evolve despite an increase in the complexity of drug dosing regimens, demand for hospital EMR integration and persistent patient safety issues.

The company believes every care setting needs to transform infusion therapy. Ivenix is first looking to bring its technology to hospitals. In March, the company secured $50 million in equity financing. This funding will allow the company to pursue FDA clearance and quickly expand its team for commercial launch, as well as some other regulatory milestones.

The Ivenix infusion system is an entirely new pump technology that emphasizes accuracy and efficiency for large volume infusion delivery and management. The platform provides immediate, secure access to patient-specific infusion and pump management information. It features intuitive user interface guides similar to a smartphone.


Don't Miss the Most Anticipated Conference of the Fall!

textadimage DeviceTalks Boston is just a few months away. More than 50 speakers and 35 exhibitors will join over 400 members of this red-hot industry, for a look inside the most important developments facing our community.

Join us for three days of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.

Take a look at our speaker line-up and more.

Pages: 1 2 3 4 5 6 7 8 9 10 11


  1. Heather, great insights on the changing needs for medtech start-ups. We were thrilled to see, Madorra, one of our collaborating partners make your top 10. Look forward to following your updates on this incredible startup space.

    • Heather Thompson says:

      They are doing some important work. Thanks, Juan. I’m excited to see the latest crop of startups for 2018 as well.

Speak Your Mind